Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1801035
Max Phase: Preclinical
Molecular Formula: C122H184N34O40S6
Molecular Weight: 2959.41
Molecule Type: Protein
Associated Items:
ID: ALA1801035
Max Phase: Preclinical
Molecular Formula: C122H184N34O40S6
Molecular Weight: 2959.41
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N4)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC3=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N2
Standard InChI: InChI=1S/C122H184N34O40S6/c1-15-55(8)91-114(189)143-75-46-197-198-47-76-106(181)140-74(45-158)105(180)142-77-48-199-202-51-80(146-119(194)96(61(14)163)151-102(177)68(30-31-88(170)171)133-84(166)41-131-100(75)175)110(185)154-95(60(13)162)118(193)138-69(35-52(2)3)98(173)129-43-87(169)148-92(57(10)159)116(191)145-78(107(182)136-70(36-62-26-28-64(164)29-27-62)103(178)152-93(58(11)160)115(190)132-56(9)97(172)128-40-85(167)134-76)49-200-201-50-79(144-113(188)89(53(4)5)149-111(186)81-24-19-33-155(81)120(195)72(139-104(179)73(44-157)141-108(77)183)37-63-39-127-66-22-17-16-21-65(63)66)109(184)153-94(59(12)161)117(192)135-67(23-18-32-126-122(124)125)101(176)137-71(38-83(123)165)99(174)130-42-86(168)147-90(54(6)7)121(196)156-34-20-25-82(156)112(187)150-91/h16-17,21-22,26-29,39,52-61,67-82,89-96,127,157-164H,15,18-20,23-25,30-38,40-51H2,1-14H3,(H2,123,165)(H,128,172)(H,129,173)(H,130,174)(H,131,175)(H,132,190)(H,133,166)(H,134,167)(H,135,192)(H,136,182)(H,137,176)(H,138,193)(H,139,179)(H,140,181)(H,141,183)(H,142,180)(H,143,189)(H,144,188)(H,145,191)(H,146,194)(H,147,168)(H,148,169)(H,149,186)(H,150,187)(H,151,177)(H,152,178)(H,153,184)(H,154,185)(H,170,171)(H4,124,125,126)/t55-,56-,57+,58+,59+,60+,61+,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,89-,90-,91-,92-,93-,94-,95-,96-/m0/s1
Standard InChI Key: GJWNMRIDLQWOGO-BDWAEGHXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 2959.41 | Molecular Weight (Monoisotopic): 2957.1733 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ireland DC, Clark RJ, Daly NL, Craik DJ.. (2010) Isolation, sequencing, and structure-activity relationships of cyclotides., 73 (9): [PMID:20718473] [10.1021/np1000413] |
Source(1):